Agiliti, Inc. (NYSE:AGTI) CFO Sells $407,600.00 in Stock

Agiliti, Inc. (NYSE:AGTI – Get Rating) CFO James B. Pekarek sold 20,000 shares of the business’s stock in a transaction on Monday, April 25th. The shares were sold at an average price of $20.38, for a total value of $407,600.00. Following the completion of the sale, the chief financial officer now owns 259,194 shares in the company, valued at approximately $5,282,373.72. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

AGTI opened at $19.57 on Thursday. Agiliti, Inc. has a one year low of $13.56 and a one year high of $26.36. The company has a market cap of $2.57 billion and a P/E ratio of 103.01. The company has a debt-to-equity ratio of 1.31, a quick ratio of 1.45 and a current ratio of 1.72. The business’s 50-day simple moving average is $19.73 and its 200-day simple moving average is $20.62.

Agiliti (NYSE:AGTI – Get Rating) last released its quarterly earnings data on Tuesday, March 8th. The company reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.16. Agiliti had a return on equity of 15.02% and a net margin of 2.31%. As a group, analysts predict that Agiliti, Inc. will post 0.85 earnings per share for the current fiscal year.

Several research firms recently issued reports on AGTI. Citigroup cut their price objective on Agiliti from $28.00 to $25.00 and set a “buy” rating on the stock in a report on Wednesday, March 9th. Zacks Investment Research downgraded Agiliti from a “hold” rating to a “sell” rating in a report on Tuesday, March 15th. Morgan Stanley cut their price target on Agiliti from $30.00 to $24.00 and set an “overweight” rating on the stock in a report on Thursday, March 10th. The Goldman Sachs Group cut their price target on Agiliti from $32.00 to $28.00 and set a “buy” rating on the stock in a report on Friday, March 11th. Finally, BMO Capital Markets upped their price target on Agiliti from $22.00 to $28.00 and gave the stock an “outperform” rating in a report on Wednesday, April 6th. One analyst has rated the stock with a sell rating, one has given a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $23.00.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC acquired a new stake in shares of Agiliti in the 4th quarter valued at about $552,000. Massachusetts Financial Services Co. MA boosted its position in shares of Agiliti by 4.3% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 2,048,176 shares of the company’s stock valued at $38,997,000 after purchasing an additional 84,279 shares during the period. Sectoral Asset Management Inc boosted its position in shares of Agiliti by 18.0% in the 3rd quarter. Sectoral Asset Management Inc now owns 977,269 shares of the company’s stock valued at $18,607,000 after purchasing an additional 148,900 shares during the period. Goldman Sachs Group Inc. acquired a new stake in shares of Agiliti in the 3rd quarter valued at about $501,000. Finally, BlackRock Inc. boosted its position in shares of Agiliti by 5.3% in the 3rd quarter. BlackRock Inc. now owns 2,998,163 shares of the company’s stock valued at $57,086,000 after purchasing an additional 149,986 shares during the period. Institutional investors and hedge funds own 99.81% of the company’s stock.

About Agiliti (Get Rating)

Agiliti, Inc provides healthcare technology management and service solutions to the healthcare industry in the United States. The company offers onsite managed services, including programs for the management, reprocessing, and logistics of medical equipment at individual facilities and integrated delivery networks to monitor and adjust equipment quantities and availability to address fluctuations in patient census and acuity.

See Also